
January 09, 2023
San Francisco, USA
Biotech Showcase™ 2023
Join Bioxodes at the Biotech Showcase™ 2023. Marc Dechamps, our CEO, will present a corporate overview on Tuesday, January 10, 2023, at 11:30 am PST.
We use necessary cookies to make our website work. We also use optional statistical, functional and marketing cookies that you can choose to decline in your preference setting. For more information about the use of cookies or our use of data, see our Cookies notice or Privacy notice
Cookies settings I agree I refuseCookies information
Our site uses tools, such as cookies, to analyze and improve your experience. You can unsubscribe below:
These settings will be kept for 24h
January 09, 2023
San Francisco, USA
Biotech Showcase™ 2023
Join Bioxodes at the Biotech Showcase™ 2023. Marc Dechamps, our CEO, will present a corporate overview on Tuesday, January 10, 2023, at 11:30 am PST.
October 13, 2022
Paris, France
HealthTech Innovation Days #4
Join Bioxodes at the HTID#4. We'll be happy to discuss about our lead product Ir-CPI and the new developments in intracerebral haemorrhage.
November 11, 2019
Hamburg, Germany
BIO-Europe Fall 2019
Edmond Godfroid, CEO and Ludwig Camusot, business developer represented Bioxodes at BIO-Europe Fall 2019.
July 07, 2019
Melbourne, Australia
ISTH 2019
Bioxodes presented up-to-date preclinical data during the annual ISTH congress on Sunday 7 July 2019 in Melbourne.
July 19, 2018
Dublin, Ireland
ISTH SSC 2018
Bioxodes presented up-to-date preclinical data during the annual ISTH SSC meeting on Thursday 19 July 2018 in Dublin.
July 10, 2017
Berlin, Germany
ISTH 2017
Bioxodes presented preclinical data for its main product, Ir-CPI, at ISTH 2017 annual congress.
May 25, 2016
Montpellier, France
ISTH SSC 2016
Bioxodes participated at the ISTH SSC 2016 annual congress.
June 20, 2015
Toronto, Canada
ISTH 2015
Bioxodes presented preclinical data for its main product, Ir-CPI, at ISTH 2015 annual congress.